Advertisements



Boston Scientific"s 25 mm Lotus Valve Wins CE Mark - Analyst Blog

Management at Boston Scientific (BSX) is enthusiastic about the commercial launch of the Lotus Valve system only seven months after its initial launch revealing their commitment to improving therapy modes and patient outcomes. Massachusetts-b.....»»

Category: topSource: zacksJul 16th, 2014

Medtronic begins initial European launch of MiniMed Duo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallJun 3rd, 2014

Horizon Pharma"s (HZNP) CEO Tim Walbert on Q1 2014 Results - Earnings Call Transcript

Horizon Pharma, Inc. (HZNP) Q1 2014 Results Earnings Conference Call May 09, 2014 08:00 AM ET Executives Bob De Vaere - EVP and Chief Financial Officer Tim Walbert - Chairman, President and CEO Tod Smith - EVP and Chief Commercial Officer Analysts.....»»

Category: topSource: seekingalphaMay 9th, 2014

Horizon Pharma Has Significant Growth Potential

By ONeil Trader:Horizon Pharma (HZNP) had a truly transformational year in 2013, and is set to deliver strong revenue growth and achieve non-GAAP profitability in 2014. The company successfully marketed Duexis and Rayos, acquired the rights for Vimovo fro.....»»

Category: topSource: seekingalphaMar 20th, 2014

Buy Horizon Pharma On Upcoming Revenue Growth

By Equity Flux: Introduction Horizon Pharma develops and commercializes products that target arthritis, pain and inflammatory diseases. The company is currently marketing Duexis, Rayos/Lodotra and the newly acquired Vimovo to orthopedic surgeons and rhe.....»»

Category: topSource: seekingalphaMar 5th, 2014

Horizon Pharma Issues Update on Feb. 10-11th FDA Joint Panel Meeting on CV Risk of NSAIDs

Horizon Pharma, Inc., (NASDAQ: HZNP), a commercial stage, specialty pharmaceutical company that markets two gastroprotective nonsteroidal anti-inflammatory drugs (NSAIDs), VIMOVO(R) (naproxen/esomeprazole magnesium) and DUEXIS(R) (ibuprofen and famotidine.....»»

Category: blogSource: benzingaFeb 11th, 2014

Horizon Pharma says Par to withdraw ANDA for generic Rayos

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallNov 22nd, 2013

Volcano Launches Crux Vena Cava Filter - Analyst Blog

Volcano expands Product portfolio with the commercial launch of Crux Vena Cava Filter Volcano Corporation (VOLC) announced the commercial release as well as the initial implantations of the novel device – Crux Vena Cava Filter (VCF). Th.....»»

Category: topSource: zacksNov 14th, 2013

Horizon Pharma Continues Cash Burn And Dilution

By Chimera Research Group: By Patrick Crutcher We last wrote on Horizon Pharma (HZNP) following their FDA approval of RAYOS, but seems not much has changed. However, the stock has risen roughly 60% year to date with no apparent change in fundamentals. W.....»»

Category: topSource: seekingalphaNov 8th, 2013

Horizon Pharma presents newe clinical data on Rayos DR tablets

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallOct 29th, 2013

Horizon Pharma Reports Clinical Data on RAYOS Tablets Which Will Be Presented at American College of Rheumatology Annual Meeting

Horizon Pharma, Inc (NASDAQ: HZNP) today announced that two published abstracts of its approved treatment RAYOS(R) (prednisone) delayed-release tablets will be presented during the American College of Rheumatology (ACR)/Association of Rheumatology Health .....»»

Category: blogSource: benzingaOct 21st, 2013

Alibaba's IPO Date September 8 on NYSE - WallStreet OTC

WallStreet OTCAlibaba's IPO Date September 8 on NYSEWallStreet OTCIn what could be termed as the world's largest initial public offering (IPO) in years, Chinese e-commerce giant Alibaba Group is expected to launch its US IPO in the first week of S.....»»

Category: topSource: googlenews15 hr. 23 min. ago

Emaar, Developer of Mideast"s Biggest Mall, to List on Stock Market

aBy Razan Alzayani DUBAI, United Arab Emirates -- Emaar Properties, the developer behind one of the world's largest shopping malls and the world's tallest tower, said Sunday it will launch an initial public offering for part of its retail businessain D.....»»

Category: topSource: thestreetAug 31st, 2014

Dubai Mall Developer Emaar to List on Stock Market - ABC News

Edmonton JournalDubai Mall Developer Emaar to List on Stock MarketABC NewsEmaar Properties, the developer behind one of the world's largest shopping malls and the world's tallest tower, said Sunday it will launch an initial public offering for par.....»»

Category: topSource: googlenewsAug 31st, 2014

Emaar Properties Plans IPO in September as Confidence Returns - Uncover California

Uncover CaliforniaEmaar Properties Plans IPO in September as Confidence ReturnsUncover CaliforniaEmaar Properties will launch initial public offer in September for stake sale up to 15 percent in its shopping malls and retail space unit. The stocks will be.....»»

Category: topSource: googlenewsAug 31st, 2014

Dubai Mall developer Emaar to list on stock market

DUBAI, United Arab Emirates (AP) — Emaar Properties, the developer behind one of the world's largest shopping malls and the world's tallest tower, said Sunday it will launch an initial public offering for part of its retail business in Dubai n.....»»

Category: topSource: yahooAug 31st, 2014

Emaar Properties, developer of the Dubai Mall, to list part of its retail unit on stock market

Emaar Properties, the developer behind one of the world's largest shopping malls and the world's tallest tower, says it will launch an initial public offering for its retail business in Dubai next month......»»

Category: topSource: foxnewsAug 31st, 2014

Dubai Mall developer Emaar to list on stock market

Emaar Properties, the developer behind one of the world's largest shopping malls and the world's tallest tower, says it will launch an initial public offering for its retail business in Dubai next month......»»

Category: marketSource: foxnewsAug 31st, 2014

Indian Prime Minister Begins Japan Trip with Sightseeing

The two countries look to deepen defense and commercial ties as they grapple with an increasingly assertive China......»»

Category: topSource: wsjAug 31st, 2014

Dubai"s Emaar to launch malls unit IPO in Sept, list it in Oct

Emaar Properties will launch an initial public offer to sell at least 15 percent of its shopping malls and retailing unit on Dubai's main stock market in September, and plans to list the shares in October. The emirate's largest real estate developer will .....»»

Category: topSource: yahooAug 31st, 2014